The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors
- 27 April 2011
- journal article
- Published by Wiley in The Journal of Physiology
- Vol. 589 (9), 2415-2431
- https://doi.org/10.1113/jphysiol.2010.202465
Abstract
Hypothermia occurs in the most severe cases of systemic inflammation, but the mechanisms involved are poorly understood. This study evaluated whether the hypothermic response to bacterial lipopolysaccharide (LPS) is modulated by the endocannabinoid anandamide(AEA) and its receptors: cannabinoid-1 (CB1), cannabinoid-2 (CB2) and transient receptor potential vanilloid-1 (TRPV1). In rats exposed to an ambient temperature of 22◦C, a moderate dose of LPS (25 - 100 μg kg−1 I.V.) induced a fall in body temperature with a nadir at ∼100 minpostinjection. This response was not affected by desensitization of intra-abdominal TRPV1 receptors with resiniferatoxin (20 μg kg - 1 I.P.), by systemic TRPV1 antagonism with capsazepine(40mg kg−1 I.P.), or by systemic CB2 receptor antagonism with SR144528 (1.4 mg kg−1 I.P.).However, CB1 receptor antagonism by rimonabant (4.6mg kg−1 I.P.) or SLV319 (15mg kg−1 I.P.)blocked LPS hypothermia. The effect of rimonabant was further studied. Rimonabant blocked LPS hypothermia when administered I.C.V. at a dose (4.6 μg) that was too low to produce systemic effects. The blockade of LPS hypothermia by I.C.V. rimonabant was associated with suppression of the circulating level of tumour necrosis factor-α. In contrast to rimonabant,the I.C.V. administration of AEA (50 μg) enhanced LPS hypothermia. Importantly, I.C.V. AEAdid not evoke hypothermia in rats not treated with LPS, thus indicating that AEA modulates LPS-activated pathways in the brain rather than thermo effector pathways. In conclusion, the present study reveals a novel, critical role of brain CB1 receptors in LPS hypothermia. Brain CB1 receptors may constitute a new therapeutic target in systemic inflammation and sepsis.Keywords
This publication has 115 references indexed in Scilit:
- Regulation of Inflammatory Pain by Inhibition of Fatty Acid Amide HydrolaseThe Journal of pharmacology and experimental therapeutics, 2010
- The Transient Receptor Potential Vanilloid-1 Channel in Thermoregulation: A Thermosensor It Is NotPharmacological Reviews, 2009
- Endogenous cannabinoids induce fever through the activation of CB1 receptorsBritish Journal of Pharmacology, 2009
- Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effectsNature Chemical Biology, 2008
- Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide‐induced alterations in circulating cytokine levels in ratsImmunology, 2008
- N-Arachidonyl Maleimide Potentiates the Pharmacological and Biochemical Effects of the Endocannabinoid 2-Arachidonylglycerol through Inhibition of Monoacylglycerol LipaseThe Journal of pharmacology and experimental therapeutics, 2008
- Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemiaProceedings of the National Academy of Sciences of the United States of America, 2008
- Central and peripheral neuroimmune responses: hyporesponsiveness during pregnancyThe Journal of Physiology, 2008
- Anandamide and Δ9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptorsJournal of Neuroimmunology, 2007
- The role of transient receptor potential vanilloid 1 in mechanical and chemical visceral hyperalgesia following experimental colitisNeuroscience, 2007